NEJM study - natural immunity to SARS2 virtually eliminates chances of reinfection or disease if reinfected

PxD

Member
Joined
Aug 13, 2020
Messages
402
Link to study

“Of 1304 identified reinfections, 413 (31.7%) were caused by the B.1.351 variant, 57 (4.4%) by the B.1.1.7 variant, 213 (16.3%) by “wild-type” virus, and 621 (47.6%) were of unknown status (Section S1 in the Supplementary Appendix). For reinfected persons, the median time between first infection and reinfection was 277 days (interquartile range, 179 to 315). The odds of severe disease at reinfection were 0.12 times (95% confidence interval [CI], 0.03 to 0.31) that at primary infection (Table 1). There were no cases of critical disease at reinfection and 28 cases at primary infection (Table S3), for an odds ratio of 0.00 (95% CI, 0.00 to 0.64). There were no cases of death from Covid-19 at reinfection and 7 cases at primary infection, resulting in an odds ratio of 0.00 (95% CI, 0.00 to 2.57). The odds of the composite outcome of severe, critical, or fatal disease at reinfection were 0.10 times (95% CI, 0.03 to 0.25) that at primary infection. Sensitivity analyses were consistent with these results (Table S2).”

Note: median 277 days between infections = at least 9 months of robust protection by natural immunity.
 

Attachments

  • 1638147128058.jpeg
    1638147128058.jpeg
    602.7 KB · Views: 10

David PS

Member
Joined
Jan 5, 2016
Messages
14,675
Location
Dark side of the moon

Similar threads

Back
Top Bottom